Discuss timing with a healthcare provider if you are on oral medications, particularly those for thyroid conditions, blood pressure, or diabetes
Simultaneously, its GLP-1 receptor agonist activity promotes glucose-dependent insulin release, slows gastric emptying, and reduces appetite through central nervous system pathways
Whilst blood in stool is not a recognised adverse reaction in the MHRA-approved Summary of Product Characteristics, patients may experience gastrointestinal side effectssuch as constipationthat can indirectly contribute to rectal bleeding
*Products under the patent are only for R&D use.
doi:10.1056/NEJMoa2403347 Nissen SE, Nicholls SJ, Sipahi I, et al